Ansell Limited designs, develops, and manufactures protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, Caribbean, and North America. More Details
Flawless balance sheet with proven track record and pays a dividend.
Share Price & News
How has Ansell's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: ANN is less volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: ANN's weekly volatility (4%) has been stable over the past year.
7 Day Return
AU Medical Equipment
1 Year Return
AU Medical Equipment
Return vs Industry: ANN exceeded the Australian Medical Equipment industry which returned 5.4% over the past year.
Return vs Market: ANN exceeded the Australian Market which returned -0.6% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Ansell's share price compared to the market and industry in the last 5 years?
Simply Wall St News
5 days ago | Simply Wall StAnsell (ASX:ANN) Has Gifted Shareholders With A Fantastic 101% Total Return On Their Investment
2 weeks ago | Simply Wall StIs Ansell Limited (ASX:ANN) Worth AU$41.7 Based On Its Intrinsic Value?
1 month ago | Simply Wall StDo Ansell's (ASX:ANN) Earnings Warrant Your Attention?
Is Ansell undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: ANN (A$37.32) is trading above our estimate of fair value (A$32.26)
Significantly Below Fair Value: ANN is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: ANN is good value based on its PE Ratio (22.5x) compared to the AU Medical Equipment industry average (38.7x).
PE vs Market: ANN is good value based on its PE Ratio (22.5x) compared to the Australian market (22.8x).
Price to Earnings Growth Ratio
PEG Ratio: ANN is poor value based on its PEG Ratio (5x)
Price to Book Ratio
PB vs Industry: ANN is good value based on its PB Ratio (2.5x) compared to the AU Medical Equipment industry average (6.9x).
How is Ansell forecast to perform in the next 1 to 3 years based on estimates from 9 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ANN's forecast earnings growth (4.6% per year) is above the savings rate (2.3%).
Earnings vs Market: ANN's earnings (4.6% per year) are forecast to grow slower than the Australian market (17.8% per year).
High Growth Earnings: ANN's earnings are forecast to grow, but not significantly.
Revenue vs Market: ANN's revenue (4.5% per year) is forecast to grow slower than the Australian market (5.1% per year).
High Growth Revenue: ANN's revenue (4.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ANN's Return on Equity is forecast to be low in 3 years time (11.7%).
How has Ansell performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ANN has high quality earnings.
Growing Profit Margin: ANN's current net profit margins (9.8%) are higher than last year (7.5%).
Past Earnings Growth Analysis
Earnings Trend: ANN's earnings have declined by 5.1% per year over the past 5 years.
Accelerating Growth: ANN's earnings growth over the past year (41.9%) exceeds its 5-year average (-5.1% per year).
Earnings vs Industry: ANN earnings growth over the past year (41.9%) exceeded the Medical Equipment industry 37.2%.
Return on Equity
High ROE: ANN's Return on Equity (11.4%) is considered low.
How is Ansell's financial position?
Financial Position Analysis
Short Term Liabilities: ANN's short term assets ($961.0M) exceed its short term liabilities ($408.4M).
Long Term Liabilities: ANN's short term assets ($961.0M) exceed its long term liabilities ($636.8M).
Debt to Equity History and Analysis
Debt Level: ANN's debt to equity ratio (37%) is considered satisfactory.
Reducing Debt: ANN's debt to equity ratio has reduced from 63.6% to 37% over the past 5 years.
Debt Coverage: ANN's debt is well covered by operating cash flow (56%).
Interest Coverage: ANN's interest payments on its debt are well covered by EBIT (15.2x coverage).
What is Ansell current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: ANN's dividend (1.82%) isn’t notable compared to the bottom 25% of dividend payers in the Australian market (2.08%).
High Dividend: ANN's dividend (1.82%) is low compared to the top 25% of dividend payers in the Australian market (5.05%).
Stability and Growth of Payments
Stable Dividend: ANN's dividends per share have been stable in the past 10 years.
Growing Dividend: ANN's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (41.1%), ANN's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: ANN's dividends in 3 years are forecast to be well covered by earnings (44.3% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Magnus Nicolin (63 yo)
Mr. Magnus R. Nicolin, BA (Stockholm), MBA (Wharton), has been the Chief Executive Officer and Managing Director of Ansell Limited since March 1, 2010. Mr. Nicolin served as the President of Europe, Middle...
CEO Compensation Analysis
Compensation vs Market: Magnus's total compensation ($USD6.98M) is above average for companies of similar size in the Australian market ($USD1.88M).
Compensation vs Earnings: Magnus's compensation has increased by more than 20% in the past year.
|MD, CEO & Executive Director||10.67yrs||US$6.98m||0.23% |
|Chief Financial Officer||1.58yrs||US$1.14m||no data|
|President of Industrial GBU||1.58yrs||US$2.72m||0.070% |
|President of Healthcare GBU||1.58yrs||US$1.22m||0.020% |
|Senior Vice President of Operations & Global Supply Chain||1.58yrs||no data||no data|
|Senior VP & Global Chief Information Officer||0.50yr||no data||no data|
|Director of Investor Relations & Treasury||0.83yr||no data||no data|
|Senior VP & Corporate General Counsel||3.33yrs||no data||no data|
|Senior VP of Business Development||no data||no data||no data|
|Chief Human Resources Officer||1.42yrs||no data||no data|
|Acting Head Human Resources||no data||no data||no data|
|Chief Commercial Officer of EMEA & APAC Region and Senior VP||3.33yrs||no data||no data|
Experienced Management: ANN's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.
|MD, CEO & Executive Director||10.67yrs||US$6.98m||0.23% |
|Independent Non-Executive Director||14.25yrs||US$171.00k||0.018% |
|Independent Chairman||1yr||US$279.17k||0.023% |
|Independent Non-Executive Director||13.25yrs||US$177.00k||0.024% |
|Independent Non-Executive Director||0.67yr||US$49.33k||0.0051% |
|Independent Non-Executive Director||3.08yrs||US$153.00k||0.046% |
|Independent Non-Executive Director||3.08yrs||US$153.00k||0.0043% |
|Independent Non-Executive Director||5yrs||US$171.00k||0.011% |
|Independent Non-Executive Director||1.58yrs||US$153.00k||0.0025% |
Experienced Board: ANN's board of directors are considered experienced (3.1 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: ANN insiders have sold more shares than they have bought in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Ansell Limited's company bio, employee growth, exchange listings and data sources
- Name: Ansell Limited
- Ticker: ANN
- Exchange: ASX
- Founded: 1893
- Industry: Health Care Supplies
- Sector: Healthcare
- Market Cap: AU$4.732b
- Shares outstanding: 128.53m
- Website: https://www.ansell.com
Number of Employees
- Ansell Limited
- 678 Victoria Street
- Level 3
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|ANSL.F||OTCPK (Pink Sheets LLC)||Yes||Ordinary Shares||US||USD||Jan 1992|
|ANN||ASX (Australian Securities Exchange)||Yes||Ordinary Shares||AU||AUD||Jan 1992|
|PD1A||DB (Deutsche Boerse AG)||Yes||Ordinary Shares||DE||EUR||Jan 1992|
|ANN||CHIA (Chi-X Australia)||Yes||Ordinary Shares||AU||AUD||Jan 1992|
|ANSL.Y||OTCPK (Pink Sheets LLC)||UNSPONSORED ADR||US||USD||Oct 2007|
Ansell Limited designs, develops, and manufactures protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, Caribbean, and North America. It operates in two segments, Healt...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/11/26 07:00|
|End of Day Share Price||2020/11/26 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.